Advertisement

Topics

Paratek Pharmaceuticals Incorporated Company Profile

01:59 EDT 22nd March 2019 | BioPortfolio

Paratek's mission is to overcome the major worldwide problem of bacterial resistance through the application of new proprietary technology and through the development of new antibiotics. Paratek has established two product development programs to identify and develop new pharmaceuticals for the treatment of infectious diseases:

The Tetracycline Resistance Project ("Tet Project") based on expertise in medicinal chemistry

The Multiple Antibiotic Resistance Project ("Mar Project") based on novel discoveries in pathogen genomics.

Location

75 Kneeland Street
Boston
MA
02111
United States of America

Contact

Phone: 617 275-0040
Fax: 617 275-0039


News Articles [434 Associated News Articles listed on BioPortfolio]

Paratek Wins Two FDA Drug Approvals for Three Conditions in Same Day

Yesterday was a good day for Paratek Pharmaceuticals. The FDA approved a Paratek antibiotic as a treatment for pneumonia and serious skin infections. That regulatory decision late Tuesday for the drug...

EU accepts marketing application for Paratek’s antibiotic

European regulators have accepted an application from Paratek Pharmaceuticals seeking approval of the broad-spectrum antibiotic omadacycline for two types of infection.

Paratek Pharma Receives FDA Approval of Nuzyra

NewsFirst and only once-daily IV and oral antibiotic to treat both Community-Acquired Bacterial Pneumonia and Acute Skin and Skin Structure Infections in nearly 20 Years.

Paratek Pharma’s CFO Pagán to Leave for Job at an Early-Stage Biotech

Douglas Pagán, chief financial officer of Paratek Pharmaceuticals (NASDAQ: PRTK) since 2017, is resigning to take a role at an undisclosed early-stage biopharmaceutical company. The Boston company sa...

Paratek Pharmaceuticals Announces Management Change

BOSTON, March 18, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative ...

Paratek Pharmaceuticals, Inc. to Host Investor Day on October 23, 2018

BOSTON, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based up...

Paratek Pharmaceuticals, Inc. 2018 Q4 - Results - Earnings Call Slides

Paratek Pharmaceuticals Presenting New Omadacycline Data at IDWeek 2018

BOSTON, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) announced today that new data from its omadacycline clinical and microbiology programs will be presented at I...

Drugs and Medications [6 Associated Drugs and Medications listed on BioPortfolio]

Urea [exact-rx, inc.]

Urea Nail Gel 45% (in a vehicle containing camphor, menthol and eucalyptus oil) Rx Only

Urea [exact-rx, inc.]

Urea Cream 45%

Sodium sulfacetamide, sulfur [exact-rx, inc.]

Sodium Sulfacetamide 10% and Sulfur 5% CleanserRx only

Nuzyra [paratek pharmaceuticals, inc.]

These highlights do not include all the information needed to use NUZYRA™ safely and effectively. See full prescribing information for NUZYRA. NUZYRA (omadacycline) for injection, for intravenous us...

Phendimetrazine tartrate [calvin, scott and company, incorporated]

Phendimetrazine Tartrate Tablets USP, 35 mg CIIIRx only

PubMed Articles [147 Associated PubMed Articles listed on BioPortfolio]

Omadacycline: First Global Approval.

Paratek Pharmaceuticals are developing omadacycline (NUZYRA™), a first-in-class orally active aminomethylcycline antibacterial, as a treatment for various bacterial infections. The drug, which is av...

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Insight into the distribution of pharmaceuticals in soil-water-plant systems.

Pharmaceuticals in agricultural soils originating from irrigation with treated wastewater and land-applied biosolids can enter field crops. However, little is known about the role of pore water in pla...

U.S. Emergency Department Visits Resulting From Nonmedical Use of Pharmaceuticals, 2016.

National data on morbidity from nonmedical use of pharmaceuticals are limited. This study used nationally representative, public health surveillance data to characterize U.S. emergency department visi...

Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective.

Chiral pharmaceuticals (CPs), including non-steroid anti-inflammatory drugs (NSAIDs), β-blockers and some herbicide and pesticides, are widely used in aquaculture, clinical treatment and many other f...

Clinical Trials [231 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1388 Associated Companies listed on BioPortfolio]

Paratek Pharmaceuticals

Paratek Pharmaceuticals, Inc. is engaged in the discovery and commercialization of new therapeutics that treat serious and life-threatening diseases, with a particular focus on the growing worldwide p...

Paratek Pharmaceuticals Incorporated

Paratek's mission is to overcome the major worldwide problem of bacterial resistance through the application of new proprietary technology and through the development of new antibiotics. Paratek has e...

Paratek Pharmaceuticals, Inc.

Paratek Pharmaceuticals, Inc. is a privately held biopharmaceutical company headquartered in Boston, MA, which is engaged in the discovery and commercialization of new therapeutics that treat life thr...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Praecis Pharmaceuticals Incorporated (MA)

PRAECIS PHARMACEUTICALS INCORPORATED is a biotechnology company focused on the discovery and development of pharmaceutical products using its proprietary LEAP™ (Ligand Evolution to Active Pharmaceut...

More Information about "Paratek Pharmaceuticals Incorporated" on BioPortfolio

We have published hundreds of Paratek Pharmaceuticals Incorporated news stories on BioPortfolio along with dozens of Paratek Pharmaceuticals Incorporated Clinical Trials and PubMed Articles about Paratek Pharmaceuticals Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Paratek Pharmaceuticals Incorporated Companies in our database. You can also find out about relevant Paratek Pharmaceuticals Incorporated Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

MRSA (methicillin-resistant Staphylococcus aureus)
MRSA (methicillin-resistant Staphylococcus aureus) is a family of bacteria with resistance to one or more major antibiotics. There are currently 17 different strains of MRSA. Two particular strains, EMRSA15 and EMRSA16  account for 96% of MRSA blood...


Corporate Database Quicklinks



Searches Linking to this Company Record